Kocher M S, Erens G, Thornhill T S, Ready J E
Department of Orthopaedic Surgery, Brigham and Women's Hospital, and the Harvard School of Public Health, Boston, Massachusetts 02115, USA.
J Bone Joint Surg Am. 2000 Nov;82(11):1531-5. doi: 10.2106/00004623-200011000-00002.
The challenge of cost-efficiency is maintaining the quality of medical care while reducing costs and eliminating unnecessary practices. The purpose of this investigation was to evaluate the cost and effectiveness of routine pathological examination of surgical specimens from patients undergoing primary total hip or knee replacement for the treatment of osteoarthritis.
Effectiveness was assessed by comparing clinical and pathological diagnoses associated with 1,234 consecutive primary total joint replacements (471 hip and 763 knee replacements) performed between 1992 and 1995 in one hospital in patients with the clinical diagnosis of osteoarthritis. Clinical and pathological diagnoses were considered concordant if they agreed, discrepant if they differed without a resultant change in patient management, and discordant if they differed with a resultant change in patient management. Cost identification was performed by determining charges, reimbursement, and costs in 1998-adjusted American dollars for both total hip and total knee replacement. The cost per health-effect was determined by calculating the cost per discrepant and discordant diagnosis.
The prevalence of concordant diagnoses was 97.6 percent (1,205 of 1,234) (95 percent confidence interval, 96.6 to 98.4 percent), the prevalence of discrepant diagnoses was 2.3 percent (twenty-eight of 1,234) (95 percent confidence interval, 1.4 to 3.1 percent), and the prevalence of discordant diagnoses was 0.1 percent (one of 1,234) (95 percent confidence interval, 0.1 to 0.3 percent). The cost per discrepant diagnosis was $4,383, and the cost per discordant diagnosis was $122,728.
Routine pathological examination of surgical specimens from patients undergoing primary total hip or knee replacement because of the clinical diagnosis of osteoarthritis had limited cost-effectiveness at our hospital due to the low prevalence of findings that altered patient management.
成本效益面临的挑战在于在降低成本和消除不必要的医疗行为的同时,维持医疗护理的质量。本研究的目的是评估对因骨关节炎接受初次全髋关节或全膝关节置换手术的患者的手术标本进行常规病理检查的成本和效果。
通过比较1992年至1995年期间在一家医院对临床诊断为骨关节炎的患者进行的1234例连续初次全关节置换手术(471例髋关节置换和763例膝关节置换)相关的临床诊断和病理诊断来评估效果。如果临床诊断和病理诊断一致,则认为它们是相符的;如果两者不同但未导致患者管理的改变,则认为是不一致的;如果两者不同且导致了患者管理的改变,则认为是不相符的。通过确定1998年调整后的美元计价的全髋关节置换和全膝关节置换的收费、报销金额和成本来进行成本识别。通过计算每个不一致和不相符诊断的成本来确定每健康效果的成本。
相符诊断的患病率为97.6%(1234例中的1205例)(95%置信区间,96.6%至98.4%),不一致诊断的患病率为2.3%(1234例中的28例)(95%置信区间,1.4%至3.1%),不相符诊断的患病率为0.1%(1234例中的1例)(95%置信区间,0.1%至0.3%)。每个不一致诊断的成本为4383美元,每个不相符诊断的成本为122728美元。
在我们医院,由于改变患者管理的检查结果患病率较低,因此对因临床诊断为骨关节炎而接受初次全髋关节或全膝关节置换手术的患者的手术标本进行常规病理检查的成本效益有限。